Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer

References

Adams, J.M. and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science281, 1322–1326.10.1126/science.281.5381.1322Search in Google Scholar

Choi, W.S., Yoon, S.Y., Chang, I.I., Choi, E.J., Rhim, H., Jin, B.K., Oh, T.H., Krajewski, S., Reed, J.C., and Oh, Y.J. (2000). Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis. J. Neurochem.74, 1621–1626.10.1046/j.1471-4159.2000.0741621.xSearch in Google Scholar

Floros, K.V., Thomadaki, H., Lallas, G., Katsaros, N., and Talieri, M. (2003). Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of Bcl2 and novel apoptosis-related gene BCL2L12. Ann. NY Acad. Sci.1010, 153–158.10.1196/annals.1299.025Search in Google Scholar

Kanavaros, P., Stefanaki, K., Valassiadou, K., Vlachonikolis, J., Mavromanolakis, M., Vlychou, M., Kakolyris, S., Gorgoulis, V., Tzardi, M., and Georgoulias, V. (1999). Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins colorectal adenocarcinomas. Med. Oncol.16, 23–30.10.1007/BF02787355Search in Google Scholar

Korsmeyer, S.J. (1999). BCL-2 gene family and the regulation of programmed cell death. Cancer Res.59, 1693s–1700s.Search in Google Scholar

Leahy, D.T., Mulcahy, H.E., O’Donoghue, D.P., and Parfrey, N.A. (1999). Bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology35, 360–367.10.1046/j.1365-2559.1999.00743.xSearch in Google Scholar

Mariadason, J.M., Arango, D., Shi, Q., Wilson, A., Corner, G., Nicholas, C., Aranes, M., Lesser, M., Schwartz, E., and Augenlicht, L.H. (2003). Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothesin. Cancer Res.63, 8791–8812.Search in Google Scholar

Meterissian, S.H., Kontogiannea, M., A-Sowaidi, M., Linjawi, A., Halwan, A., Jamison, B., and Edwardes, M. (2001). Bcl-2 is a useful prognostic marker in Dukes’ B colon cancer. Ann. Surg. Oncol.8, 533–537.Search in Google Scholar

Nahta, R., and Esteva, F.J. (2003). Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer. Semin. Oncol.30 (Suppl. 16), 143–149.10.1053/j.seminoncol.2003.08.016Search in Google Scholar

Ogura, E., Senzaki, H., Yamamoto, D., Yoshida, R., Takada, H., Hioki, K., and Tsubura, A. (1999). Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol. Rep.6, 365–369.10.3892/or.6.2.365Search in Google Scholar

Reed, J.C. (1999). Dysregulation of apoptosis in cancer. J. Clin. Oncol.17, 2941–2953.10.1200/JCO.1999.17.9.2941Search in Google Scholar

Reed, J.C. (2002). Apoptosis-based therapies. Nat. Rev. Drug Dis.1, 111–121.10.1038/nrd726Search in Google Scholar

Reed, J.C. (2003). Apoptosis-targeted therapies in cancer. Cancer Cell3, 17–22.10.1016/S1535-6108(02)00241-6Search in Google Scholar

Reed, J.C., Zha, H., Aime-Sempe, C., Takayama, S., and Wang, H.G. (1996). Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv. Exp. Med. Biol.406, 99–112.10.1007/978-1-4899-0274-0_10Search in Google Scholar

Scorilas, A., Black, M.H., Talieri, M., and Diamandis, E.P. (2000). Genomic organization of the human protein arginine methyltransferase 1 gene (PRMT1): differential expression of splice variants in breast cancer. Biochem. Biophys. Res. Commun.278, 349–359.10.1006/bbrc.2000.3807Search in Google Scholar

Scorilas, A., Kyriakopoulou, L., Yousef, G., Ashworth, L., Kwamie, A. and Diamandis, E.P. (2001). Molecular cloning, physical mapping and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH3 domain of the Bcl-2 family. Genomics72, 217–221.10.1006/geno.2000.6455Search in Google Scholar

Sjostrom, J., Blomqvist, C., von Boguslawski, K., Bengtsson, N.O., Mjaaland, I., Malmstrom, P., Ostenstadt, B., Wist, E., Valvere, V., Takayama, S., Reed, J.C., and Saksela, E. (2002). The predictive value of bcl-2, bax, bcl-XI, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin. Cancer Res.8, 811–816.Search in Google Scholar

Sun, X.F., Bartik, Z., and Zhang, H. (2003). Bcl-2 expression is a prognostic factor in the subgroups of patients with colorectal cancer. Int. J. Oncol.23, 1439–1443.10.3892/ijo.23.5.1439Search in Google Scholar

Talieri, M., Diamandis, E.P., Katsaros, N., Gourgiotis, D., and Scorilas, A. (2003). Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb. Haemost.89, 1081–1088.10.1055/s-0037-1613411Search in Google Scholar

Tamm, I., Schriever, F., and Dorken, B. (2001). Apoptosis implications of basic research for clinical oncology. Lancet Oncol.2, 33–42.10.1016/S1470-2045(00)00193-5Search in Google Scholar